Clinical Trials Browser

Completed × Interventional × ispinesib × Clear all

NCT00095992 2023-08-04

SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00089973 2018-02-26

Study Of Ispinesib In Subjects With Breast Cancer

Phase 2 Completed

50 enrolled 12 charts

Breast Neoplasms

NCT00136578 2017-09-25

Ispinesib In Combination With Carboplatin In Patients With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT00095628 2017-03-06

SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Phase 2 Completed

21 enrolled 10 charts

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms

NCT00103311 2015-03-02

SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer

Phase 2 Completed

64 enrolled 7 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT00354250 2013-06-05

Ispinesib in Treating Patients With Metastatic or Unresectable Kidney Cancer

Phase 2 Completed

Carcinoma, Renal Cell

NCT00095953 2013-05-17

SB-715992 in Treating Patients With Metastatic or Recurrent Malignant Melanoma

Phase 2 Completed

Melanoma

NCT00096499 2013-01-25

SB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or Paclitaxel

Phase 2 Completed

Prostatic Neoplasms

NCT00363272 2013-01-16

Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma

Phase 1 Completed

CNSLymphoidSarcoma

Familial ependymoma, Astrocytoma, Burkitt Lymphoma, Medulloblastoma, Spinal Cord Neoplasms, Choroid Plexus Neoplasms, Optic Nerve Glioma, Dendritic Cell Sarcoma, Interdigitating

NCT00098826 2013-01-11

SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes

Phase 1 Completed

Classical hematologyLymphoidOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00085813 2010-10-04

Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT00097409 2010-10-04

Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer

Phase 2 Completed

Ovarian Neoplasms, Recurrence

NCT00119171 2008-10-16

Ispinesib In Combination With Capecitabine In Patients With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor Cancer

NCT00169520 2008-10-16

SB-715992 In Combination With Docetaxel In Patients With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor Cancer